All News about Incyte Corp
![](https://mms.businesswire.com/media/20210608005435/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg)
From MorphoSys AG
Via AccessWire
![](https://mms.businesswire.com/media/20210604005569/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/christina-victoria-craft-whsnkiwwpec-unsplash.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_549.png)
![](https://www.investors.com/wp-content/uploads/2018/12/stock-drugs-bottles-14-adobe.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_542.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-1884775_1920_73.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://mms.businesswire.com/media/20210520005078/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20210519005952/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_335.png)
![](https://mms.businesswire.com/media/20210517005235/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/dices-over-newspaper-2656028_1920_69.jpg?width=720)
![](https://mms.businesswire.com/media/20210512006007/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20210511006085/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Incyte Corp (INCY) Q1 2021 Earnings Call Transcript
May 04, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_186.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_63.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210504005512/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20210503005077/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20210427005031/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_90.png)
![](https://mms.businesswire.com/media/20210423005324/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20210423005325/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20210420005436/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_61.jpg)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.